Meds & supplements › Idecabtagene vicleucel
Medicine
Idecabtagene vicleucel
ABECMA is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after two or more prior lines of therapy including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody.
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Drug facts
- Used for
- ABECMA is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after two or more prior lines of therapy including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody.
Side effects, and when to stop
The following adverse reactions are described elsewhere in the labeling:
- Early Death
- Cytokine Release Syndrome
- Neurologic Toxicities
- Hemophagocytic Lymphohistiocytosis (HLH)/Macrophage Activation Syndrome (MAS)
- Hypersensitivity Reactions
- Infections
- Prolonged Cytopenias
- Hypogammaglobulinemia
Who should not take it
None.
Other medicines and interactions
Drug/Laboratory Test Interactions
HIV and the lentivirus used to make ABECMA have limited, short spans of identical genetic material (RNA). Therefore, some commercial HIV nucleic acid tests may yield false-positive results in patients who have received ABECMA.
Storing it
Store ABECMA frozen in the vapor phase of liquid nitrogen (less than or equal to minus 130°C).
Thaw ABECMA prior to infusion.
Cite this page
- NLM
sofidex [Internet]. Daloreum; c2026. Idecabtagene vicleucel; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/idecabtagene-vicleucel
- APA 7th
sofidex. (2026, August 3). Idecabtagene vicleucel. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/idecabtagene-vicleucel
- AMA 11th
Idecabtagene vicleucel. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/idecabtagene-vicleucel
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.